PT - JOURNAL ARTICLE AU - Cao, Longbing AU - Liu, Qing TI - How varying intervention, vaccination, mutation and ethnic conditions affect COVID-19 resurgence AID - 10.1101/2021.08.31.21262897 DP - 2023 Jan 01 TA - medRxiv PG - 2021.08.31.21262897 4099 - http://medrxiv.org/content/early/2023/02/07/2021.08.31.21262897.short 4100 - http://medrxiv.org/content/early/2023/02/07/2021.08.31.21262897.full AB - After a year of the unprecedented COVID-19 pandemic in 2020, the world has been overwhelmed by COVID-19 resurgences and virus mutations up to today. Here we develop a dynamic intervention, vaccination and mutation-driven epidemiological model with sequential interventions influencing epidemiological compartments and their state transition. We quantify epidemiological differences between waves under fatal viral mutations, the impacts of control or relaxation interventions and fatal virus mutations on resurgence under vaccinated or unvaccinated conditions, and estimate potential trends under varying interventions and mutations. Comprehensive analyses - between waves, with or without vaccinations, across representative countries with distinct ethnic and cultural backgrounds, what-if scenario simulations on second waves, and future 30-day trend - in two COVID-19 waves in Germany, France, Italy, Israel and Japan over 2020 and 2021 obtain quantitative empirical indication of the influence of strong vs. weak interventions, various combinations of control vs. relaxation strategies, and different transmissibility levels of coronavirus mutants on the behaviors and patterns of different waves and resurgences and future infection trends. The analyses quantify that (1) virus mutations, intervention fatigue, early relaxations, and lagging interventions, etc. may be common reasons for the resurgences observed in many countries; (2) timely strong interventions such as full lockdown will contain resurgence; (3) some resurgences relating to fatal mutants could have been better contained by either carrying forward the effective interventions from their early waves or implementing better controls and timing; (4) insufficient evidence is found on distinguishing the infection between unvaccinated and vaccinated countries while substantial vaccinations ensure much low mortality rate and high recovery rate; (5) resurgences with substantial vaccination have a much lower mortality rate and a higher recovery rate than those without vaccination; and (6) in the absence of sufficient vaccination, herd immunity and effective antiviral pharmaceutical treatments and with more infectious mutations, the widespread early or fast relaxation of interventions including public activity restrictions likely result in a COVID-19 resurgence. We also find the severity, number and timing of control and relaxation interventions determines a protection-deconfinement tradeoff, which can be used to evaluate the containment effect and the opportunity of resurgence and reopening under vaccination and fatal mutations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is sponsored in part by the Australian Research Council Discovery grant (DP190101079) and ARC Future Fellowship grant (FT190100734).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:n/aI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe source codes and data are shared in Github, with the hyperlink included in the paper. https://github.com/QingLIU67/waves_comparison